Fate Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $89.0M | $88.6M | $64.8M | $49.1M | $54.0M | $9.1M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $102.6M | $93.3M | $65.7M | $49.9M | $54.7M | $9.8M |
| Property, Plant & Equipment | $2.6M | $1.6M | $2.2M | $1.2M | $810.0K | $1.2M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $105.3M | $95.0M | $68.0M | $51.2M | $55.6M | $11.1M |
| Liabilities | ||||||
| Accounts Payable | $1.7M | $934.0K | $996.0K | $645.0K | $682.0K | $1.2M |
| Total Current Liabilities | $11.0M | $15.2M | $13.4M | $4.6M | $4.6M | $4.9M |
| Long-Term Debt | $14.8M | $2.5M | $10.7M | $18.1M | $1.8M | $1.7M |
| Total Liabilities | $28.1M | $21.9M | $29.9M | $22.8M | $4.7M | $63.9M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-218.8M | $-175.8M | $-142.4M | $-112.4M | $-86.5M | — |
| Total Stockholders' Equity | $77.2M | $73.2M | $38.0M | $28.3M | $50.8M | $-52.8M |